Anuh Pharma Ltd.
Fundamentals
- Market cap
- ₹785 cr
- P/E
- 19.14×
- ROE
- 14.52%
- Debt / equity
- 0.03
- Div yield
- 1.91%
- 52-week range
- 66.72 — 115.00
Company snapshot
Anuh Pharma Ltd.
Pharmaceuticals
₹763 cr
P/E 18.58×
Latest quarter · Mar 2026
Sales₹202 cr
Net profit₹12 cr
Op. margin+9.8%
EPS₹1.17
Strength & growth
Debt / equity0.03×
Current ratio2.11×
Sales CAGR+8.9%
EPS CAGR−0.2%
The timeline — 4 notes on Anuh Pharma Ltd.
May 2026
- 21 May 26 · 12:53 PM IST Brief Brief · Earnings · Micro cap
Anuh Pharma's FY26 revenue rose 16.6% but profit fell 13.3%
The divergence between topline growth and bottomline decline is the standout signal in an otherwise routine annual results filing. Dividend recommended at ₹1.50 per share.
- 20 May 26 · 11:56 PM IST Brief Brief · Earnings · Micro cap
Anuh Pharma revenue up 16%, but profit slips 13% in FY26
Top-line growth couldn't protect margins: PAT fell to ₹41.05 cr despite a ₹771.66 cr top line.
- 20 May 26 · 10:52 PM IST Brief Brief · Earnings · Micro cap
Anuh Pharma's profit slipped 13% even as revenue rose 17% in FY26
The ₹771 cr pharma company saw a margin squeeze; board recommends ₹1.50 dividend.
- 20 May 26 · 9:58 PM IST Brief Brief · Earnings · Micro cap
Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
Revenue rose to ₹771.66 cr but PAT fell to ₹41.05 cr; board recommends ₹1.50/sh dividend.